CAD 0.01
(0.0%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | - CAD | -100.0% |
2022 | 35.02 Thousand CAD | -74.02% |
2021 | 134.82 Thousand CAD | 0.0% |
2020 | - CAD | 0.0% |
2019 | - CAD | 0.0% |
2018 | - CAD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q2 | - CAD | 0.0% |
2024 Q1 | - CAD | 0.0% |
2023 Q4 | - CAD | 0.0% |
2023 FY | - CAD | -100.0% |
2023 Q1 | - CAD | -100.0% |
2023 Q3 | - CAD | 0.0% |
2023 Q2 | - CAD | 0.0% |
2022 Q2 | 5300.00 CAD | -75.35% |
2022 FY | 35.02 Thousand CAD | -74.02% |
2022 Q4 | 4720.00 CAD | 34.86% |
2022 Q3 | 3500.00 CAD | -33.96% |
2022 Q1 | 21.5 Thousand CAD | -37.75% |
2021 FY | 134.82 Thousand CAD | 0.0% |
2021 Q2 | 49.64 Thousand CAD | 0.0% |
2021 Q1 | - CAD | 0.0% |
2021 Q3 | 50.64 Thousand CAD | 2.01% |
2021 Q4 | 34.54 Thousand CAD | -31.79% |
2020 FY | - CAD | 0.0% |
2020 Q1 | - CAD | 0.0% |
2020 Q3 | - CAD | 0.0% |
2020 Q2 | - CAD | 0.0% |
2020 Q4 | - CAD | 0.0% |
2019 Q4 | - CAD | 0.0% |
2019 Q3 | - CAD | 0.0% |
2019 Q1 | - CAD | 0.0% |
2019 FY | - CAD | 0.0% |
2019 Q2 | - CAD | 0.0% |
2018 Q3 | - CAD | 0.0% |
2018 FY | - CAD | 0.0% |
2018 Q4 | - CAD | 0.0% |
2018 Q2 | - CAD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Aquarius Surgical Technologies Inc. | 205.24 Thousand CAD | 100.0% |
Cannabix Technologies Inc. | - CAD | NaN% |